Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Immunology|May 11, 1992
Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposureR T Davey, L R Deyton, J A Metcalf, et al.
Annals of Internal Medicine|August 15, 1989
Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)J A Kovacs, L Deyton, R Davey, et al.
The Journal of Pediatrics|May 1, 1989
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infectionF M Balis, P A Pizzo, J Eddy, et al.
Annals of Internal Medicine|August 1, 1989
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infectionH Masur, F P Ognibene, R Yarchoan, et al.
Annals of Internal Medicine|July 1, 1989
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trialH C Lane, J Falloon, R E Walker, et al.
The American Journal of Medicine|February 1, 1993
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet)M A Polis, M D deSmet, B F Baird, et al.
The Journal of Clinical Investigation|August 1, 1993
Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160J A Kovacs, M B Vasudevachari, M Easter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
The Journal of Infectious Diseases|November 1, 1994
Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virusR T Davey, C M Boenning, B R Herpin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661R T Davey, R L Dewar, G F Reed, et al.
Pageof 7